According to preliminary statistics of its financial department, Zhejiang Huahai Pharmaceutical Co., Ltd. predicts that the net profit owned by shareholders of the listed company from January to September 2020 will be between RMB 820 million and RMB 870 million, with an increase of between about 60% and 70% compared with the same period of the year before. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss from January to September 2020 will be between RMB 745 million and RMB 820 million, with an increase of between about 100% and 120% compared with the same period of the year before.